Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Annmarie Bell, Vice President and Chief HR Officer of Standex International Corporation (SXI), reported multiple equity transactions on 08/22/2025 and 08/23/2025 related to vesting of incentive awards and tax-withholding sales. Phantom stock and restricted stock units vested, generating 613, 279 and 567 underlying shares from different awards, while portions of vested restricted stock/performance units were sold to pay taxes at an effective price of $210.48 per share. After these transactions the reporting person beneficially owned 8,606 shares directly. Performance share units were granted with a 0–250% payout formula and certain PSUs cliff vesting at three years; reported achievement for performance-based phantom units was 52%.
Standex International Corp director and President/CEO/Chairman David A. Dunbar reported multiple equity transactions on 08/22/2025 and 08/23/2025. Vesting events converted phantom stock units and restricted stock units into common shares, and some shares were sold to cover taxes. The filing shows net changes in direct beneficial ownership across several transactions with reported per-share price $210.48 for taxable sales. After the reported transactions Mr. Dunbar held both direct common shares (ending at 18,826.9759) and indirect interests (115,576 shares held by a trust), plus outstanding unvested performance and restricted awards.
Sarcevic Ademir, an officer (Vice President/CFO/Treasurer) of Standex International Corp. (SXI), reported multiple equity transactions on 08/22/2025 and 08/23/2025. The filing shows vesting of Phantom Stock Units and Restricted Stock Units under the companys 2018 Omnibus Incentive Plan, sales of shares to cover taxes on vesting, and a grant of 2,490 Performance Share Units that cliff vest on 08/23/2028. Several transactions were executed at a price of $210.48 per share, reflecting share sales tied to tax withholding. Following the reported transactions, the filing lists 12,249 beneficially owned shares of common stock (direct). The document describes formulaic achievement levels for performance awards (actual achievement 52% for certain phantom awards) and specifies vesting schedules for RSUs and PSUs.
Standex International Corp (SXI) reporting person Max Arets, VP and Chief Information Officer, filed a Form 4 disclosing equity activity on 08/22/2025 and 08/23/2025. 176 restricted stock units vested on 08/22/2025, resulting in 176 shares acquired at a deemed price of $210.48 and leaving 1,494.632 shares beneficially owned after the transaction. Also disclosed was a sale of 43 shares on 08/22/2025 to cover taxes. On 08/23/2025 the filer received grants and awards: 506 performance share units (cliff vesting at three years, 0–250% payout), 506 restricted stock units (vest one-third annually), and 684 phantom/contingent units combined (506 and 178) vesting in 2028.
Standex International Corporation (SXI) filing a Form 144 reports a proposed sale of 1,085 common shares by a person associated with the issuer. The shares are held at Fidelity Brokerage Services and the proposed approximate aggregate market value is $227,739.90 with an approximate sale date of 08/26/2025 on the NYSE. The shares were acquired by restricted stock vesting on 08/23/2025 and the payment is listed as compensation. The filer also disclosed a prior sale by the same person of 3,047 common shares on 08/06/2025 that generated gross proceeds of $584,446.61. The filer attests there is no undisclosed material adverse information and includes the standard signature and legal warnings.
Barbara Joanne Edwards, a director of Standex International Corporation (SXI), reported transactions dated 08/22/2025 under Form 4. The filing shows vesting and contingent purchase activity under the company’s Management Stock Purchase Plan: 387 shares were deemed acquired (transaction code M) at a price of $63.59, and after the reported transactions Ms. Edwards beneficially owned 5,646 common shares directly. The filing also documents phantom stock unit activity that vests and converts into common stock: 387 units related to the 08/22/2025 activity and a contingent purchase of 209 phantom units exercisable/expiring on 08/23/2028, which will result in 209 common shares when vested. The transactions reflect compensation-plan vesting rather than open-market trades.
Standex International Corporation (SXI) director Thomas J. Hansen reported transactions dated 08/22/2025 that increased his beneficial ownership. The filing shows 1,107 shares acquired through vesting of phantom stock units under the company’s Management Stock Purchase Plan at a $0 purchase price, with those units exercisable into common stock on 08/23/2025. A contingent purchase of 599 additional phantom units (to convert to common stock) was reported as vesting on 08/23/2028. The form lists a post-transaction beneficial ownership figure of 9,546.254 shares as reported on the form. The filing is signed by Alan J. Glass on 08/26/2025.
Andy L. Nemeth, a director of Standex International Corporation (SXI), purchased 2,000 shares of the issuer's common stock on 08/25/2025 at a weighted-average price of $209.4959 per share. The filing states the purchase was completed in multiple transactions at prices ranging from $209.4596 to $209.50 and that the reporting person now beneficially owns 4,500 shares. The Form 4 identifies the reporting person as a director and was filed individually. No derivative transactions or other dispositions are reported in this filing.
Robin J. Davenport, a director of Standex International Corporation (SXI), acquired 149 phantom stock units on 08/23/2025 under the Management Stock Purchase component of the companys 2018 Omnibus Incentive Plan. These units are a contingent purchase that will vest and be settled in the form of 149 shares of common stock on 08/23/2028. The reported transaction shows a conversion price of $0, and the ownership is reported as direct with 149 shares beneficially owned following the transaction. The filing indicates this award vests three years after purchase and is intended to convert to common stock at vesting.
Standex International Corporation (SXI) insider filing shows that reporting person CANNON CHARLES H JR reported a transaction dated 08/23/2025 acquiring 599 Phantom Stock Units under the company's Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan. The units were purchased as contingent phantom stock that will vest three years after the purchase date and will be settled in the form of 599 shares of Common Stock on 08/23/2028.
The report lists the securities as directly owned following the transaction, with an exercise/settlement price of $0 for the underlying common shares. The form indicates the transaction was reported on a Form 4 with an 08/23/2025 transaction date and includes a standard explanatory note describing the contingent purchase and vesting schedule.